fig4

Figure 4. Rates of recurrent HCC by treatment group and SVR status. Colored bars represent rates of recurrent HCC by SVR status, with 95%CIs depicted by the capped vertical black lines. Rates of recurrent HCC were as follows: DAA group, overall: 16.76/100py (95%CI: 10.75, 22.91), SVR: 18.17/100py (95%CI: 3.84, 33.58) and non-SVR: 44.16/100py, (95%CI: 0.006, 90.35). IFN group, overall: 14.31/100py (95%CI: 10.17, 19.16), SVR: 11.01/100py (95%CI: 4.85, 17.63), non-SVR: 16.89/100py (95%CI: 10.05, 24.02). Untreated group: 25.69/100py (95% CI: 14.44,37.27). “Overall” group included some patients not included in SVR or non-SVR groups. SVR: sustained viral response; HCC: HCC: hepatocellular carcinoma; CI: confidence interval; IFN: interferon; DAA: direct-acting antiviral